Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines

– Brings Together Oncology, Inflammation and Research Data Science Teams to Foster Scientific Collaboration –

– One of Three Foster City Projects Supporting Gilead’s $32 Billion U.S. Investment and 3,000 High-Quality Domestic Jobs –

Gilead Sciences, Inc. (NASDAQ:GILD) today celebrated the opening of its 182,000-square-foot Research Center at its Foster City headquarters, expanding capabilities in oncology, inflammation and research data science to advance medicines for some of the world’s most challenging diseases. The new Research Center builds on Gilead's longstanding presence in California. Today, Gilead employs approximately 11,000 people across the United States, including more than 7,400 in California and nearly 4,700 in the Bay Area.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260908951870/en/